BSF Enterprise Plc (LON:BSFA)
London · Delayed Price · Currency is GBP · Price in GBX 0.8766
-0.3734 (-29.87%)
Mar 6, 2026, 4:22 PM GMT
BSF Enterprise Market Cap
BSF Enterprise has a market cap or net worth of 106.98 thousand as of March 6, 2026. Its market cap has decreased by -96.70% in one year.
Market Cap
106.98K
Enterprise Value
-42.04K
Revenue
52.84K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.88
Market Cap Chart
Since July 26, 2019, BSF Enterprise's market cap has decreased from 1.02M to 106.98K, a decrease of -89.48%. That is a compound annual growth rate of -28.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 106.98K | -95.61% |
| Dec 31, 2025 | 2.44M | -16.73% |
| Dec 31, 2024 | 2.93M | -72.35% |
| Dec 29, 2023 | 10.59M | -26.28% |
| Dec 30, 2022 | 14.37M | 841.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genflow Biosciences | 9.38M |
| Futura Medical | 7.28M |
| IXICO | 7.27M |
| CRISM Therapeutics | 6.21M |
| Cizzle Biotechnology Holdings | 5.95M |
| OptiBiotix Health | 5.94M |
| Nuformix | 4.96M |
| Theracryf | 4.41M |